CELL INTELLIGENCE · 肿瘤细胞治疗研究

抗 CD22 CAR-NK 细胞治疗高效杀伤淋巴瘤细胞

High yield killing of lymphoma cells by anti-CD22 CAR-NK cell therapy.

CD19/CD22 双特异性嵌合抗原受体 NK-92 细胞的开发与评价

CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated.

CD22 重定向 CAR NK-92 细胞对 B 细胞淋巴瘤的免疫治疗

Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells.

我们的数据显示，过继转移 m971-BBZ NK-92 细胞可作为 B 细胞淋巴瘤免疫治疗的一种有前景的策略。